Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share (GLMD)

Historical Holders from Q3 2024 to Q3 2025

Symbol
GLMD on Nasdaq
CUSIP
M47238148
Type / Class
Equity / Ordinary Shares, NIS 1.80 par value per share
Shares outstanding
5.59M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
72.8K
Holdings value
$102K
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
13
Number of buys
3
Number of sells
-7
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share (GLMD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CVI Investments, Inc. 3.1% -57.1% $347K 173K 0% CVI Investments, Inc. Sep 30, 2025
Baharaff Allen 2.6% $60.5K 44.1K Allen Baharaff Dec 31, 2024

Institutional Holders of Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share (GLMD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 72.8K $102K -$18.5K $1.38 13
2025 Q2 76K $140K +$46.2K $1.86 14
2025 Q1 55.9K $80.4K +$15.9K $1.44 12
2024 Q4 44.8K $143K +$125K $3.19 11
2024 Q3 5.59K $38.3K +$38.3K $6.86 9